The Pfizer COVID-19 vaccine is associated with increased myocarditis incidence. Constantly evolving evidence regarding incidence and case fatality of COVID-19 and myocarditis related to infection or vaccination, creates challenges for risk-benefit analysis of vaccination. Challenges are complicated further by emerging evidence of waning vaccine effectiveness, and variable effectiveness against variants.
View Article and Find Full Text PDFBackground: General practitioners play an important role in the detection and clinical management of influenza. The Australian Sentinel Practice Research Network (ASPREN) has been collecting data from sentinel GPs on selected conditions, including influenza-like illness (ILI), since 1991 to inform public health authorities of communicable disease activity in the community.
Methods: Weekly incidence of ILI data reported by ASPREN GPs in 2007-2008 was compared with data from two separate surveillance systems: New South Wales data from FluTracking, an online self reporting ILI surveillance system; and national laboratory notifications of influenza reported to the National Notifiable Diseases Surveillance System between 2003 and 2008.